Recombinant IL23A (Brazikumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL23A (Brazikumab Biosimilar) antibody (ABIN7488120) specifically detects IL23A (Brazikumab Biosimilar) in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7488120
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant IL23A (Brazikumab Biosimilar) antibody (ABIN7488120)
Target
IL23A (Brazikumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL23A (Brazikumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Brazikumab Biosimilar - Anti-IL23A mAb
-
Characteristics
- Antibody Type: IgG2-lambda
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG2 lambda
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL23A (Brazikumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
AMG-139,MEDI2070
Brazikumab is a human monoclonal antibody targeting IL23A that can be potentially used in the treatment of Crohn's disease (CD). -
CAS-No
- 1610353-18-8
Target
-
You are here:
